Castle Creek Biosciences, Inc.Pelthos Therapeutics Inc.
Pelthos Therapeutics agreed to acquire Castle Creek Biosciences in a stock-for-stock merger under which Castle Creek stockholders will receive 5,200,000 shares of Pelthos common stock, repre…AI-generated